Patent · US Expired

Treatment of conditions relating to hormone deficiencies by administration of progestins

US7427609B2 · kind B2 · utility

61Cited by
8References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 3, 2003
Grant dateSep 23, 2008
Priority date
Expiry dateSep 15, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P15/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes methods for preventing endometrial hyperplasia associated with estrogen therapy through the administration of a progestin agent. The methods presented may include starting the administration of a progestin agent at a high dose, and then lowering the dose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.